Volume 2, Issue 4
Research Articlep. 603
Changes in mesenteric blood flow during intracranial hypertension due to acute elevations in intra-abdominal pressure
Author(s): Shmuel Avital, Samuel Szomstein, Oscar E Brasesco, Danny Rosin, Pablo Paolucci, Turab Pishori, Klaus Thaler, Ravindra Mailapur, Laurence Sands, Steven Wexner and Raul J Rosenthal
Appendices
Acknowledgement: Volume2; Issue4
Appendices
Appendices: Volume2; Issue4
Appendices
Glossary: Volume2; Issue4
Review Articlep. 677
Management and treatment of lithium-induced nephrogenic diabetes insipidus
Author(s): Christopher K Finch , Tyson WA Brooks, Peggy Yam and Kristi W Kelley
Review Articlep. 659
Treatment of early rheumatoid arthritis
Author(s): Karim Raza, Mike Salmon and Christopher D Buckley
Review Articlep. 649
Therapy of vascular dementia: perspectives and milestones
Author(s): Rita Moretti, Paola Torre, Rodolfo M. Antonello and Giuseppe Cazzato
Review Articlep. 641
Pathophysiology and treatment of alveolar-capillary dysfunction in chronic heart failure
Author(s): Marco Guazzi
Review Articlep. 623
Role of immunologic and inflammatory factors in the development of endometriosis: indications for treatment strategies
Author(s): Attila Mihalyi, Kyama C Mutinda, Peter Simsa, Sophie Debrock, Jason M Mwenda and Thomas M D\'Hooghe
Research Articlep. 615
Caspofungin versus amphotericin B treatment of Aspergillus fumigatus in kidneys of chronically immunosuppressed infected mice
Author(s): Emily Hickey, George Abruzzo, Joel Bowman, Cameron Douglas, Charles Gill, Paul Liberator, Andrew Misura, Bill Pikounis and Ken Bartizal
Research Articlep. 609
Passiflora incarnata in the treatment of attention-deficit hyperactivity disorder in children and adolescents
Author(s): Shahin Akhondzadeh, MR Mohammadi and F Momeni
Editorialp. 511
Antibiotic dosing: do we dose to cure the individual or do we treat the greater societal needs?
Author(s): Joseph M Blondeau and Glenn S Tillotson
Research Articlep. 597
Risk for new-onset diabetes mellitus after transplantation: implication of advanced age and immunosuppressive therapy
Author(s): Moro O Salifu, Dale Distant, Dhiren M Haria, Mariya Stratilatova, Sheni Meghani, Joon Hong, Nabil Sumrani, Eli Friedman and Mariana S Markell
Research Articlep. 587
Outcomes of a multidisciplinary team approach to cardiovascular risk reduction in patients with diabetes mellitus
Author(s): Angela M Taylor, Coleen A McNamara, Anne Hedelt, Cherie Chaney, Mary Lou Perry, Thomas M Miller III, Karen D Tyler and Anthony L McCall
Short Reportp. 577
Diagnosis of chronic radiating lower back pain without overt focal neurologic deficits: what is the value of segmental nerve blocks?
Author(s): Andre P Wolff, Gerbrand J Groen and Oliver HG Wilder-Smith
Drug Evaluationp. 569
Miglustat: substrate reduction therapy for glycosphingolipid storage disorders
Author(s): Robin H Lachmann
Drug Evaluationp. 559
Cilansetron: a novel, high-affinity 5-HT3 receptor antagonist for irritable bowel syndrome with diarrhea predominance
Author(s): Georges Coremans
Drug Evaluationp. 533
Carbamazepine ER capsules for the treatment of bipolar I disorder
Author(s): Richard H Weisler
Conference Scenep. 521
From vector toxicity to successful clinical evaluation: highlights of the 2nd annual meeting of the British Society for Gene Therapy
Author(s): Lisa D Cooper, Martin L Read, Karen Doyle, Ann Logan and Ana Maria Gonzalez
Bulletin Boardp. 517
